With a projected compound annual growth rate (CAGR) of 26.4% from 2021 to 2031, the global CRISPR gene editing industry is anticipated to increase significantly and will be worth $16,329.8 million by that time. A growing geriatric population, the surge in demand for better food and medical products, significant advancements in gene therapy, and the creation of quick CRISPR-based point-of-care (POC) tests in response to the COVID-19 pandemic are all major contributors to the market expansion.
More and more people throughout the world are looking for improved food and medical goods that provide better nutrition, quality, and safety. The production of novel crops with desirable features, such as greater yield, disease resistance, and improved nutritional content, is made possible by the CRISPR gene editing technology. Additionally, CRISPR gene editing has enormous potential for medical advancements, including the treatment of cancer, infectious diseases, and genetic disorders. The proliferation of CRISPR gene editing techniques across businesses is being fueled by the growing need for better food and healthcare products.
Get A Sneak Peek into Our Market Research Reports by Downloading a Free Sample Today- https://marketdatalibrary.com/download-sample/3942
Additionally, developments in gene therapy are completely changing the healthcare sector. CRISPR and other gene editing technologies offer previously unheard-of prospects for precise alterations in the human genome, perhaps leading to the treatment of hereditary illnesses that were previously incurable. The market for CRISPR gene editing is expanding as a result of ongoing investments in healthcare research & development as well as the rising incidence of chronic and genetic disorders. The COVID-19 pandemic has also sped up the development of quick point-of-care CRISPR testing for virus identification, encouraging the use of CRISPR gene editing methods in diagnostic applications.
Highlighted with 87 tables and 86 figures, this 180-page report “Global CRISPR Gene Editing Market 2021-2031 by Offering (Products, Services), Application (Biomedical, Agriculture, Industrial, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions & Research Centers, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global CRISPR gene editing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
View Report Scope and Latest Developments in the Market:
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global CRISPR gene editing market in every aspect of the classification from perspectives of Offering, Application, End User, and Region.
Don’t Settle for Generic Reports – Personalize Your Data with Our Customization Options: https://marketdatalibrary.com/free-customization/3942
Based on Offering, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- CRISPR Products
o Kits & Enzymes
Vector-Based Cas9
DNA-Free Cas9
o Databases & Libraries
o Design Tools
o Antibodies
o CRISPR Plasmid & Vector
o Other Products
- CRISPR Services
o gRNA Design & Vector Construction
o Cell Line Engineering
o Microbial Gene Editing
o DNA Synthesis
o Other Services
Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Biomedical Research & Therapy
o Gene Therapy
o Drug Discovery
o Diagnostics
o Other Biomedical Applications
- Agriculture
- Industrial Use
- Other Applications
By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Pharmaceutical Companies
- Biotechnology Companies
- Academic Institutions & Research Centers
- Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
- North America (U.S., Canada, and Mexico)
- Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Switzerland, Russia, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
- APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
- South America (Brazil, Chile, Argentina, Rest of South America)
- MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Offering, Application, and End User, over the forecast years are also included.
TO KNOW HOW COVID-19 PANDEMIC AND RUSSIA UKRAINE WAR WILL IMPACT THIS MARKET – REQUEST SAMPLE
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abcam, Inc.
Agilent Technologies, Inc.
Applied StemCell, Inc.
Caribou Biosciences, Inc.
Cellecta, Inc.
CRISPR Therapeutics AG
Editas Medicine, Inc.
GeneCopoeia, Inc.
GeneScript Biotech Corporation
Horizon Discovery Group PLC
Integrated DNA Technologies, Inc.
Intellia Therapeutics Inc.
Lonza Group Ltd.
Merck KGaA
New England Biolabs, Inc.
Origene Technologies, Inc.
Rockland Immunochemicals, Inc.
Synthego Corporation
System Biosciences LLC
Takara Bio, Inc.
Thermo Fisher Scientific, Inc.
ToolGen, Inc.
About Market Data Library:
Market Data Library is committed to providing clients with high-quality market research that is tailored to their specific needs. The Market Data Library provides corporate intelligence studies that ensure reliable and accurate research data across a diverse range of industries, including Health Care, Chemicals, Packaging, ICT, Automotive, Industrial Automation, Agriculture, and Finance. Our team is comprised of various departments, including sales, operations, finance, research, and analytics, as well as the scientist and data scientist teams. Our business offerings portray the most up-to-date, rational information a company needs to compete effectively. To guarantee that our clients have access to information and insights whenever they need them, we provide 24/7 research support.
Contact Us
Market Data Library
Tel: +1-(718)-312-8686
Email: sales@marketdatalibrary.com
Website: marketdatalibrary.com/